ELECSYS BRAHMS PCT 05056888200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-06-01 for ELECSYS BRAHMS PCT 05056888200 manufactured by Roche Diagnostics.

Event Text Entries

[76429010] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[76429011] The customer stated that they received erroneous results for one patient sample tested for elecsys brahms pct (pct) on a cobas e 411 immunoassay analyzer (e411). It was asked, but it is not known if an erroneous result was reported outside of the laboratory. The sample initially resulted as > 100 ng/ml. The sample was diluted x10 and repeated three times, resulting as 5. 8 ng/ml, 5. 8 ng/ml, and 5. 5 ng/ml. The sample was repeated on (b)(6) 2017, resulting as 80. 64 ng/ml. The sample was also diluted x10 and repeated on (b)(6) 2017, resulting as 5. 8 ng/ml. No adverse events were alleged to have occurred with the patient. The e411 analyzer serial number was (b)(4).
Patient Sequence No: 1, Text Type: D, B5


[78605247] An update of the repeat results that were obtained at the customer site was provided. The sample was provided for investigation, where it was tested on a cobas e 411 immunoassay analyzer. The sample was measured without dilution and after dilution with both multiassay diluent and pct negative patient serum. The e411 analyzer used for investigation was serial number (b)(4). Pct reagent lot number 203580, with an expiration date of april 2018 was used on this analyzer. The customer results could not be reproduced. The results of the diluted sample obtained during investigations was much higher than those obtained by the customer. The reason why the customer obtained much lower results in dilutions must be related to an unknown local issue within the customer lab. Per product labeling, only samples with results that are outside of the measuring range (>100 ng/ml) should be diluted. The low recovery with diluted sample measurements in the investigation can be attributed to dilutions performed outside of product labeling recommendations.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-01120
MDR Report Key6604367
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-06-01
Date of Report2017-06-27
Date of Event2017-05-14
Date Mfgr Received2017-05-15
Date Added to Maude2017-06-01
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameELECSYS BRAHMS PCT
Generic NameDEVICE TO DETECT AND MEASURE PROCALCITONIN (PCT) IN HUMAN CLINICAL SPECIMENS
Product CodePMT
Date Received2017-06-01
Model NumberNA
Catalog Number05056888200
Lot Number203580
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.